Advancing vaccine strategies against toxoplasma gondii: Mechanistic insights and translational challenges

Toxoplasma gondii is a major global health concern, particularly affecting pregnant women and immunocompromised individuals who are at increased risk of severe or congenital disease. In the field of microbial immunology, considerable research has focused on elucidating the intricate host-parasite interplay that governs both susceptibility and protection. Recent advances have highlighted the promise of novel vaccine approaches—ranging from subunit and vector-based formulations to mRNA and nanoparticle platforms—yet translating fundamental immunological discoveries into robust, clinically effective vaccines remains an ongoing challenge. Pivotal studies have shed light on the molecular and cellular mechanisms underpinning immunity to T. gondii, identifying key antigens, immune cell mediators, and regulatory networks crucial for protection. However, critical gaps persist regarding the precise immune correlates of protection, the ways in which the parasite subverts host defenses, and the optimization of vaccine-induced responses to achieve durable immunity.This Research Topic aims to advance mechanistic understanding of how diverse vaccine modalities influence host immunity to T. gondii, as well as to identify the immune pathways and molecular signatures that underpin effective protection. The primary goal is to elucidate how innate recognition, cytokine signaling, and adaptive responses—including specific T and B cell dynamics—can be harnessed and modulated by innovative vaccine platforms. Furthermore, the collection seeks to push the boundaries of translational research by integrating insights from molecular parasitology, immunology, and bioengineering. Key objectives include understanding the strategies T. gondii employs to evade immune surveillance, optimizing antigen selection and vaccine delivery, and defining predictive biomarkers for vaccine responsiveness. By fostering a mechanistic and interdisciplinary perspective, this Research Topic aims to fuel the rational design of new vaccines, ultimately informing public health interventions against toxoplasmosis.The scope of this Research Topic encompasses studies that dissect the molecular, cellular, and systemic mechanisms of vaccine-induced immunity to T. gondii, as well as factors impacting vaccine efficacy and translation. The focus is on mechanistic insights and translational challenges, rather than purely descriptive or outcome-based studies. To gather further insights in vaccine innovation and immune protection against T. gondii, we welcome articles addressing, but not limited to, the following themes:-Molecular mechanisms of host-pathogen interaction and immune evasion by T. gondii-Antigen discovery, subunit, vectored, mRNA, and nanoparticle-based vaccine platforms-Innate immune sensing, cytokine signaling, and their roles in shaping adaptive responses-T and B cell-mediated immunity and immune correlates of vaccine-induced protection-Strategies to enhance antigen presentation, immunogenicity, and vaccine delivery-Predictive biomarkers and immunological endpoints for evaluating vaccine efficacy-Challenges and advances in translating preclinical vaccine findings to clinical settingsWe welcome Original Research, Review, Mini Review, Perspective, Brief Research Report, and Methods that provide mechanistic, translational, or integrative insights into vaccine-induced immunity against Toxoplasma gondii. Submissions may include experimental or computational studies, preclinical or clinical investigations, and interdisciplinary approaches that explore host-pathogen interactions, immune correlates of protection, vaccine development and delivery strategies, or predictive biomarkers. Contributions that bridge molecular parasitology, immunology, and translational vaccine research are particularly encouraged to advance both fundamental understanding and practical applications. The topic editors declare no conflict of interest Topic editors: Fernando Gómez-Chávez, Rima McLeod Source: https://www.frontiersin.org/research-topics/77812/advancing-vaccine-strategies-against-toxoplasma-gondii-mechanistic-insights-and-translational-challenges